Medication Fact Sheets
|
December 4, 2024

Vortioxetine for Depression: Mechanism, Benefits, Risks, and Safety Tips

Written By
Medically Reviewed by
Updated On
December 16, 2024

Struggling with depression can feel like wading through a fog that clouds your mood and your mind. Vortioxetine, a next-generation antidepressant, offers a novel approach by addressing both emotional symptoms and cognitive challenges associated with depression.

Approved by the FDA (Food and Drug Administration) for major depressive disorder (MDD), vortioxetine sets itself apart by acting on multiple serotonin pathways. Its dual action aims to improve mood while addressing cognitive difficulties, such as focus and memory, often experienced in depression.

This article examines how Vortioxetine works, its benefits, potential risks, and its role in modern antidepressant treatments.

[signup]

What is Vortioxetine?

Vortioxetine is a prescription medication for major depressive disorder (MDD). Known by its brand name Trintellix (or Brintellix in some regions), it is classified as a serotonin modulator and stimulator (SMS).Β 

Vortioxetine works through a multimodal mechanism, targeting multiple serotonin pathways, and is designed to address both mood and cognitive symptoms.

History and FDA Approval

Developed by Lundbeck and Takeda Pharmaceuticals, vortioxetine was approved by the FDA in 2013 for adults with MDD.Β 

Its approval marked a significant step forward in antidepressant treatment by addressing not only mood symptoms but also cognitive deficits, a key yet often overlooked aspect of depression.

Unique Characteristics

Vortioxetine offers several distinctive features that set it apart from other antidepressants.

Multimodal Mechanism

Vortioxetine combines serotonin reuptake inhibition with receptor modulation, targeting pathways such as serotonin 1A (5-HT1A) and serotonin 3 (5-HT3).Β 

This unique mechanism enhances serotonin activity, supporting better mood regulation and cognitive processing.

Cognitive Benefits

Studies suggest that Vortioxetine may improve cognitive symptoms, such as focus, memory, and decision-making, in individuals with depression.

Tolerability

While mild side effects such as nausea may occur, vortioxetine is generally well-tolerated, and some studies indicate it may have a lower risk of sexual dysfunction or weight gain compared to certain other antidepressants.

How Does Vortioxetine Work?

Vortioxetine improves mood and cognitive function by targeting multiple serotonin pathways, offering a more comprehensive approach to treating depression.

Interaction with Serotonin Receptors

Vortioxetine inhibits serotonin reuptake and modulates several serotonin receptors. It interacts with serotonin receptors, such as activating 5-HT1A to enhance serotonin release and blocking 5-HT3 and 5-HT7 receptors, which may support mood regulation and reduce anxiety.

Effects on Mood, Cognition, and Neuroplasticity

Beyond enhancing mood, vortioxetine improves cognitive functions like memory, attention, and decision-making. It also supports neuroplasticity, the brain's ability to reorganize and form new neural connections, aiding recovery from depression-related cognitive deficits.

Comparison with SSRIs

Unlike selective serotonin reuptake inhibitors (SSRIs), which primarily inhibit serotonin reuptake, vortioxetine's broader receptor activity allows it to target both mood and cognitive symptoms, providing a more effective treatment for depression.

Uses and Benefits of Vortioxetine

Vortioxetine is primarily used to treat major depressive disorder (MDD), but its unique properties also offer cognitive benefits and potential applications in other mental health conditions.

Treating Major Depressive Disorder (MDD)

Vortioxetine is FDA-approved for treating MDD in adults.

It helps relieve common depressive symptoms such as persistent sadness, lack of interest, and fatigue by targeting multiple serotonin pathways, improving mood regulation and emotional balance.

Cognitive Improvements Beyond Mood Enhancement

In addition to improving mood, vortioxetine enhances cognitive functions like memory, attention, and decision-making.Β 

These cognitive benefits are beneficial for individuals with depression-related cognitive dysfunction, which often impacts daily life and decision-making abilities.

Off-Label Uses Under Research

Vortioxetine is being researched for potential off-label uses, including generalized anxiety disorder, social anxiety disorder, and cognitive impairments linked to neurodegenerative conditions like Alzheimer's disease. These uses are not FDA-approved and require further study.

Its potential to enhance cognition makes it a promising option for treating these disorders.

Side Effects and Risks

Vortioxetine is generally well-tolerated, but as with any medication, it can cause side effects. Understanding the potential risks of using it safely and effectively is essential.

Most side effects are typically mild and may diminish as the body adjusts to the medication. However, some individuals may experience:

  • Nausea: Common, especially at the beginning of treatment
  • Headache: Frequently reported, often resolving as the body adjusts
  • Dizziness: Typically mild and temporary during the initial phase of treatment

Rare But Serious Risks

Seek immediate medical attention if these symptoms occur:

  • Serotonin Syndrome: A potentially life-threatening condition marked by symptoms like agitation, hallucinations, and muscle rigidity. Immediate medical care is essential.
  • Severe Allergic Reactions: Signs include rash, difficulty breathing, or swelling, necessitating urgent medical attention.

Contraindications and Drug Interactions

Specific individuals should avoid Vortioxetine due to potential interactions or specific health conditions:

  • Contraindications: People taking monoamine oxidase inhibitors (MAOIs) or those allergic to Vortioxetine should not use it.
  • Drug Interactions: Caution is advised when combining Vortioxetine with other serotonergic medications or those affecting liver enzymes, as this may increase the risk of adverse effects.

Vortioxetine vs. Other Antidepressants

Vortioxetine offers a distinct approach to treating depression, setting it apart from other common antidepressants. Understanding how it compares to these options can help determine the best treatment for individuals with depression.

How it Compares to SSRIs, SNRIs, and TCAs

Vortioxetine differs from other antidepressants in its mechanism and effects:

SSRIs (Selective Serotonin Reuptake Inhibitors)

SSRIs, such as fluoxetine or sertraline, focus on inhibiting serotonin reuptake. Vortioxetine also modulates serotonin receptors, which may provide additional benefits, such as improvements in cognitive symptoms.

SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

SNRIs, like venlafaxine, act on both serotonin and norepinephrine. Vortioxetine primarily targets serotonin but with broader receptor activity, which may help address both mood and cognitive symptoms with fewer side effects than SNRIs.

TCAs (Tricyclic Antidepressants)

TCAs, such as amitriptyline, affect a wide range of neurotransmitters but often cause significant side effects like sedation and weight gain. Vortioxetine's more selective mechanism may reduce side effects while offering mood and cognitive support.

FAQs About Vortioxetine

Here are answers to some frequently asked questions about Vortioxetine, offering key insights into its use and safety.

How long does it take for Vortioxetine to work?

Vortioxetine typically begins to show effects on mood within 2-4 weeks. However, cognitive improvements may take longer, with some individuals noticing benefits after 6-8 weeks of treatment.

Can it be combined with other medications?

Vortioxetine may be combined with other medications, but care must be taken with other serotonergic drugs (e.g., SSRIs, SNRIs) due to the risk of serotonin syndrome. Always consult a healthcare provider before combining Vortioxetine with any other medications.

Is it safe to consume alcohol while on Vortioxetine?

It is advisable to avoid or limit alcohol while taking Vortioxetine. Alcohol can enhance side effects like dizziness, drowsiness, and impaired judgment and may interfere with the medication's effectiveness.

[signup]

Key Takeaways

  • Vortioxetine is approved to treat major depressive disorder (MDD) and is designed to address both mood and cognitive symptoms, though individual responses may vary.
  • By targeting serotonin reuptake and modulating multiple serotonin receptors, Vortioxetine offers a comprehensive approach to addressing both emotional and cognitive symptoms of depression.
  • As a promising treatment for complex depression, Vortioxetine may be considered under the guidance of a healthcare provider to ensure its appropriateness based on individual needs and potential interactions.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Vortioxetine should only be used under the guidance of a qualified healthcare provider. Individual responses to antidepressants vary, and this medication may not be appropriate for everyone. Always consult your healthcare provider for personalized treatment recommendations. If you experience side effects or symptoms of serotonin syndrome, seek immediate medical attention.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

BΓ©try, C., EtiΓ©vant, A., Oosterhof, C., Ebert, B., Sanchez, C., & Haddjeri, N. (2011). Role of 5-HT3 receptors in the antidepressant response. Pharmaceuticals, 4(4), 603–629. https://doi.org/10.3390/ph4040603

Chu, A., & Wadhwa, R. (2023, May 1). Selective serotonin reuptake inhibitors. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554406/

Cleveland Clinic. (n.d.). Vortioxetine (Trintellix). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/19369-vortioxetine-tablets

Cleveland Clinic. (2018). Serotonin syndrome | Cleveland Clinic. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17687-serotonin-syndrome

Cleveland Clinic. (2023a). SNRIs. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/24797-snri

Cleveland Clinic. (2023b, March 1). Antidepressants. Cleveland Clinic; Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/9301-antidepressants-depression-medication

Cleveland Clinic. (2023c, May 3). SSRIs. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/24795-ssri

Cloyd, J. (2023a, March 7). An integrative medicine approach to fatigue. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue

Cloyd, J. (2023b, August 15). A root cause medicine protocol for patients with generalized anxiety: Comprehensive lab testing, therapeutic diet, and supplements. Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-protocol-for-patients-with-generalized-anxiety-comprehensive-lab-testing-therapeutic-diet-and-supplements

Cloyd, J. (2024, January 22). Interpreting Liver Enzyme Tests: ALT, AST, and ALP in Liver Health Monitoring. Rupa Health. https://www.rupahealth.com/post/interpreting-liver-enzyme-tests-alt-ast-and-alp-in-liver-health-monitoring

D’Agostino, A., English, C. D., & Rey, J. A. (2015). Vortioxetine (brintellix): A new serotonergic antidepressant. Pharmacy and Therapeutics, 40(1), 36. https://pmc.ncbi.nlm.nih.gov/articles/PMC4296590/

DeCesaris, L. (2023, December 12). Elevating mood with nutraceuticals: A functional medicine perspective. Rupa Health. https://www.rupahealth.com/post/elevating-mood-with-nutraceuticals-a-functional-medicine-perspective

FDA. (2024). US food and drug administration. Fda.gov. https://www.fda.gov/

Garcia-Garcia, A. L., Newman-Tancredi, A., & Leonardo, E. D. (2013). P5-HT1A receptors in mood and anxiety: Recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology, 231(4), 623–636. https://doi.org/10.1007/s00213-013-3389-x

Hall-Flavin, D. (2017). Antidepressants and alcohol: What's the concern? Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/depression/expert-answers/antidepressants-and-alcohol/faq-20058231

JosΓ© MarΓ­a GarcΓ­a-Alberca, De, P., Gris, E., Mendoza, S., Lopez, M., Barbancho, M. Á., Lara, J. P., & EncarnaciΓ³n Blanco-Reina. (2024). Effectiveness of vortioxetine treatment on depression and cognitive functions in patients with Alzheimer's disease: A 12-month, retrospective, observational study. Journal of Personalized Medicine, 14(9), 918–918. https://doi.org/10.3390/jpm14090918

Khakham, C. (2023a, May 23). An integrative medicine approach to Alzheimer's disease: Testing, nutrition, and supplements. Rupa Health. https://www.rupahealth.com/post/to-functional-medicine-labs-that-help-individualize-treatment-for-alzheimers-disease

Khakham, C. (2023b, July 28). Top labs to run bi-annually on your depression patients. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-depression-patients

Kotzalidis, G. D., Lombardozzi, G., Matrone, M., Amici, E., Perrini, F., Cuomo, I., & De Filippis, S. (2021). Vortioxetine vs. other antidepressants in patients with major depressive episode with or without substance use disorder. Current Neuropharmacology, 19. https://doi.org/10.2174/1570159x19666210113150123

Kresge, K. (2023, February 21). An integrative medicine approach to depression. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-depression

Mayo Clinic. (n.d.). Vortioxetine (oral route) description and brand names - Mayo Clinic. Www.mayoclinic.org. https://www.mayoclinic.org/drugs-supplements/vortioxetine-oral-route/description/drg-20061387

Montano, C. B., Jackson, W. C., Vanacore, D., & Weisler, R. H. (2022). Practical advice for primary care clinicians on the safe and effective use of vortioxetine for patients with major depressive disorder (MDD). Neuropsychiatric Disease and Treatment, Volume 18, 867–879. https://doi.org/10.2147/ndt.s337703

Moraczewski, J., & Aedma, K. K. (2022). Tricyclic antidepressants. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557791/

National Institute of Mental Health. (2022). Social anxiety disorder: More than just shyness. National Institute of Mental Health. https://www.nimh.nih.gov/health/publications/social-anxiety-disorder-more-than-just-shyness

PubChem. (n.d.). Vortioxetine. Pubchem.ncbi.nlm.nih.gov. https://pubchem.ncbi.nlm.nih.gov/compound/Vortioxetine

Rupa Heath. (n.d.) Serotonin. Rupa Health. https://www.rupahealth.com/biomarkers/serotonin

Sarkisyan, G., Roberts, A. J., & Hedlund, P. B. (2010). The 5-HT7 receptor is a mediator and modulator of antidepressant-like behavior. Behavioural Brain Research, 209(1), 99–108. https://doi.org/10.1016/j.bbr.2010.01.022

Tahrier Sub Laban, & Abdolreza Saadabadi. (2023, July 17). Monoamine oxidase inhibitors (MAOI). Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK539848/

Yoshimura, H. (2023a, September 6). Top labs to run bi-annually on your patients who suffer from major depressive disorder. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-who-suffer-from-major-depressive-disorder

Yoshimura, H. (2023b, November 6). Neuroplasticity and nutrition: The role of diet in brain resilience and repair. Rupa Health. https://www.rupahealth.com/post/neuroplasticity-and-nutrition-the-role-of-diet-in-brain-resilience-and-repair

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless β€” and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! πŸ‘‹ Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! πŸ‘‹ Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.